Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma
    3.
    发明申请
    Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma 有权
    用于预测神经母细胞瘤预后的微阵列和预测神经母细胞瘤预后的方法

    公开(公告)号:US20050287541A1

    公开(公告)日:2005-12-29

    申请号:US10947249

    申请日:2004-09-23

    IPC分类号: C12M1/34 C12Q1/68

    摘要: A microarray for predicting the prognosis of neuroblastoma, wherein the microarray has 25 to 45 probes related to good prognosis, which are hybridized to a gene transcript whose expression is increased in a good prognosis patient with neuroblastoma and are selected from 96 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 1 to 96 or their partial continuous sequences or their complementary strands, and 25 to 45 probes related to poor prognosis, which are hybridized to a gene transcript whose expression is increased in a poor prognosis patient with neuroblastoma and are selected from 104 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 97 to 200 or their partial continuous sequences or their complementary strands.

    摘要翻译: 一种用于预测神经母细胞瘤的预后的微阵列,其中所述微阵列具有与良好预后相关的25至45个探针,其与在具有神经母细胞瘤的良好预后患者中表达增加的基因转录物杂交,并且选自96个由核苷酸 序列Seq。 ID No.1至96或其部分连续序列或其互补链,以及与不良预后相关的25至45个探针,其与在具有神经母细胞瘤的不良预后患者中表达增加的基因转录物杂交并选自104个多核苷酸 由Seq的核苷酸序列组成。 ID号97至200或其部分连续序列或其互补链。

    Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma
    4.
    发明授权
    Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma 有权
    用于预测神经母细胞瘤预后的微阵列和预测神经母细胞瘤预后的方法

    公开(公告)号:US07601532B2

    公开(公告)日:2009-10-13

    申请号:US10947249

    申请日:2004-09-23

    摘要: A microarray for predicting the prognosis of neuroblastoma, wherein the microarray has 25 to 45 probes related to good prognosis, which are hybridized to a gene transcript whose expression is increased in a good prognosis patient with neuroblastoma and are selected from 96 polynucleotides consisting of the nucleotide sequences of SEQ. ID NOs. 1, 5, 6, 14. 16, 17, 19, 22-24, 28, 29, 31, 37, 39, 40, 43, 44, 47-52, 54, 57-60, 62, 64, 65, 67, 68, 72-75, 77, 78, 80-82, 84, 87, 89-91, 94, 100, 103, 112, 113, 118, 120, 129, 130, 132, 136, 138, 142, 144, 145, 148, 150-153, 155, 158-160, 163-165, 169-171, 173, 174, 177, 178, 180-182, 184, 186, 187, 189, 191, 192, 194, 195, 198-200 or their partial continuous sequences or their complementary strands, and 25 to 45 probes related to poor prognosis, which are hybridized to a gene transcript whose expression is increased in a poor prognosis patient with neuroblastoma and are selected from 104 polynucleotides consisting of the nucleotide sequences of SEQ. ID NOs. 2-4, 7-13, 15, 18, 20, 21, 25-27, 30, 32-36, 38, 41, 42, 45, 46, 53, 55, 56, 61, 63, 66, 69-71, 76, 79, 83, 85, 86, 88, 92, 93, 95-99, 101, 102, 104-111, 114-117, 119, 121-128, 131, 133-135, 137, 139-141, 143, 146, 147, 149, 154, 156, 157, 161, 162, 166-168, 172, 175, 176, 179, 183, 185, 188, 190, 193, 196, 197 or their partial continuous sequences or their complementary strands.

    摘要翻译: 一种用于预测神经母细胞瘤的预后的微阵列,其中所述微阵列具有与良好预后相关的25至45个探针,其与在具有神经母细胞瘤的良好预后患者中表达增加的基因转录物杂交,并且选自96个由核苷酸 SEQ。 身份证号 1,5,6,14,16,17,19,22-24,28,29,31,37,39,40,43,44,47-52,54,57-60,62,64,65, 67,68,72-75,77,78,80-82,84,87,89-91,94,100,103,112,113,118,120,129,130,132,136,138, 144,145,148,150-153,155,158-160,163-165,169-171,173,174,177,178,180-182,184,186,187,189,191,192,194, 195,198-200或其部分连续序列或其互补链,以及与不良预后相关的25至45个探针,其与在具有神经母细胞瘤的不良预后患者中表达增加的基因转录物杂交,并且选自104个多核苷酸 的SEQ ID NO: 身份证号 2-4,7-13,15,18,20,21,25-27,30,32-36,38,41,42,45,46,53,55,56,61,63,66,69- 71,76,79,83,85,86,88,92,93,95-99,101,102,104-111,114-117,119,121-128,131,133-135,137,139- 141,143,146,147,149,154,156,157,161,162,166-168,172,175,176,179,183,185,188,190,193,196,197或其部分连续序列 或其互补链。